These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. ALKYLATING AGENTS DERIVED FROM INDOLES. IV. SYNTHESIS OF THE 5-NITROGEN MUSTARD OF INDOLE-3-CARBOXYLIC ACID. DEGRAW J; GOODMAN L J Med Chem; 1964 Mar; 7():213-5. PubMed ID: 14187378 [No Abstract] [Full Text] [Related]
5. [TUMOUR CHEMOTHERAPY. XII. SYNTHESIS OF NITROGEN MUSTARD RELATED TO ANTIARTHRITICS]. DENG RS Yao Xue Xue Bao; 1962 Jan; 9():18-22. PubMed ID: 14074948 [No Abstract] [Full Text] [Related]
6. A NITROGEN MUSTARD DERIVATIVE OF 6-MERCAPTOPURINE. LEVIN G; SUGIURA K; BROWN GB J Med Chem; 1964 May; 7():357-8. PubMed ID: 14204978 [No Abstract] [Full Text] [Related]
8. SYNTHESIS OF N-PHOSPHORYLATED DERIVATIVES OF NITROGEN MUSTARDS WITH LATENT CYTOTOXICITY. FRIEDMAN OM; BOGER E; GRUBLIAUSKAS V; SOMMER H J Med Chem; 1963 Jan; 6():50-8. PubMed ID: 14174031 [No Abstract] [Full Text] [Related]
9. [TUMOUR CHEMOTHERAPY. XIII. SOME SCHIFF'S BASES CONTAINING THE NITROGEN MUSTARD GROUPING]. LI SW; KAO YS Yao Xue Xue Bao; 1962 Mar; 9():167-73. PubMed ID: 14073962 [No Abstract] [Full Text] [Related]
10. NITROGEN MUSTARDS DERIVED FROM 3,4-DIHYDRO-2, 4-DIOXO-1(2H)-PYRIMIDINEPROPIONIC AND -BUTYRIC ACIDS. MARTINEZ AP; LEE WW; GOODMAN L J Med Chem; 1965 Mar; 8():187-9. PubMed ID: 14332657 [No Abstract] [Full Text] [Related]
11. POTENTIAL ANTICANCER AGENTS. II. THE SYNTHESIS OF SOME NITROGEN MUSTARD CONTAINING SULFONES AND THIOSULFINATES. HIRSCH AF; PIANTADOSI C; IRVIN JL J Med Chem; 1965 Jan; 8():10-4. PubMed ID: 14287239 [No Abstract] [Full Text] [Related]
12. POTENTIAL ANTICANCER AGENTS. LXXIX. AROMATIC NITROGEN MUSTARDS DERIVED FROM CYSTEINE. IWAMOTO RH; ACTON EM; ROSS LO; SKINNER WA; BAKER BR; GOODMAN L J Med Chem; 1963 Jan; 6():43-6. PubMed ID: 14174029 [No Abstract] [Full Text] [Related]
13. ACRIDINE AND QUINOLINE ANALOGS OF NITROGEN MUSTARD WITH AMIDE SIDE CHAINS. PECK RM; BREUNINGER ER; MILLER AJ; CREECH HJ J Med Chem; 1964 Jul; 7():480-2. PubMed ID: 14221130 [No Abstract] [Full Text] [Related]
14. SYNTHESIS OF POSSIBLE CANCER CHEMOTHERAPEUTIC COMPOUNDS BASED ON ENZYME APPROACH. V. TETRAZOLIUM NITROGEN MUSTARDS. TSOU KC; SU HC J Med Chem; 1963 Nov; 6():693-6. PubMed ID: 14184928 [No Abstract] [Full Text] [Related]
15. CYANO ANALOGS OF PHENOLIC NITROGEN MUSTARDS. BURKE WJ; BROWN JE; WEATHERBEE C; CURTIS DH J Med Chem; 1964 Sep; 7():670-1. PubMed ID: 14233188 [No Abstract] [Full Text] [Related]
16. [STUDIES ON NITROGEN MUSTARD DERIVATIVES, WITH SPECIAL REFERENCE TO THE PHARMACOLOGICAL ACTION OF NITROGEN MUSTARD DERIVATIVES CONTAINING ONLY L BETA-CHLOROETHYL GROUP]. YAMAMOTO I; IWATSUBO K; KIMURA H Nihon Yakurigaku Zasshi; 1963 Sep; 59():382-90 CONTD. PubMed ID: 14092711 [No Abstract] [Full Text] [Related]
17. STUDIES ON THE MECHANISM OF THE GROWTH-INHIBITORY ACTION OF GALACTOFLAVIN IN RATS. LANE M Cancer Res; 1964 Nov; 24():1811-3. PubMed ID: 14230927 [No Abstract] [Full Text] [Related]
18. STUDIES ON FATTY ACID ESTERS OF FLAVINS. III. NUTRITIONAL AND ARIBOFLAVINOSIS-CURING EFFECTS. YAGI K; OKUDA J; KOBAYASHI M J Vitaminol (Kyoto); 1963 Jun; 9():168-76. PubMed ID: 14066704 [No Abstract] [Full Text] [Related]
19. LABORATORY AND CLINICAL STUDIES WITH THE RIBOFLAVIN ANTAGONIST, GALACTOFLAVIN. LANE M; BRINDLEY CO Proc Soc Exp Biol Med; 1964 May; 116():57-61. PubMed ID: 14200132 [No Abstract] [Full Text] [Related]